TCM
INFI

Tang Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Tang Capital Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-460,000
Closed -$2.42M – 15
2016
Q1 		$2.42M Buy
+460,000
New +$2.82M 1.1% 10

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tang Capital Management's INFI Position: Q2 2016 in Review

Tang Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2016, closing a stake of 460,000 shares — an estimated $2.42M sold.

Tang Capital Management first reported a position in INFI in Q1 2016 and held it in 1 quarter. The position peaked at $2.42M in Q1 2016. 107 funds tracked by Wall St. Rank hold INFI as of Q2 2016.

  • Tang Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Tang Capital Management sold 460,000 Infinity Pharmaceuticals, Inc. shares in Q2 2016, an estimated $2.42M.
  • Tang Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2016 and held it in 1 quarter.
  • Tang Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $2.42M in Q1 2016.
  • 107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2016.

Based on Tang Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.